Effect of pantoprazole on the course of reflux-associated laryngitis: a placebo-controlled double-blind crossover study

被引:104
作者
Eherer, AJ
Habermann, W
Hammer, HF
Kiesler, K
Friedrich, G
Krejs, GJ
机构
[1] Karl Franzens Univ Graz, Dept Internal Med, Graz, Austria
[2] Karl Franzens Univ Graz, Dept Otorhinolaryngol, Graz, Austria
关键词
gastroesophageal reflux; GERD; laryngitis; reflux-associated laryngitis;
D O I
10.1080/00365520310001860
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background: The optimal management of patients with reflux-associated laryngitis is unclear. We performed a placebo-controlled crossover trial in patients with proven reflux disease and associated laryngitis to determine the effect of pantoprazole and to gain information on the natural course of the disease. Methods: Sixty-two consecutive non-smoking patients with hoarseness and proven laryngitis were examined. Scores with respect to the larynx and for subjective complaints were determined and 24-h pH-metry to assess acid reflux in the lower oesophagus and pharynx was performed. Patients with pathologic reflux were given the chance to enter a double-blinded randomized crossover trial with pantoprazole 40 mg b.i.d. and placebo for a duration of 3 months each, separated by a 2-week washout period. Results: Twenty-four of 62 patients showed pathological reflux; 21 patients were included in the study and 14 concluded all parts of the study. Both pantoprazole and placebo resulted in a marked improvement in laryngitis scores (decrease of 8.0 +/- 1.4 versus 5.6 +/- 2.6; no significant difference between the 2 treatments) and symptoms after the first 3 months (decrease of oesophageal symptom score of 2.2 +/- 1.4 versus 5.4 +/- 2.8; decrease of laryngeal scores of 8.3 +/- 3.6 versus 10.3 +/- 3.9; also no significant difference between the 2 treatments). A second pH-metry 2 weeks thereafter proved the persistence of reflux in most of these patients. Switching to pantoprazole led to a further improvement of scores. In the group switched to placebo there was recurrence only in a minority of patients. Conclusions: The self-limited nature of reflux-associated laryngitis in non-smokers is largely underestimated. Laryngitis improves despite the persistence of reflux. Pantoprazole may be helpful especially in relieving acute symptoms, but the advantage of long-term treatment over placebo has been greatly overestimated.
引用
收藏
页码:462 / 467
页数:6
相关论文
共 25 条
[1]   CHEST PAIN AS A CONSEQUENCE OF ABNORMAL VISCERAL NOCICEPTION [J].
CANNON, RO ;
BENJAMIN, SB .
DIGESTIVE DISEASES AND SCIENCES, 1993, 38 (02) :193-196
[2]   PHARYNGEAL LOCALIZATION OF SYMPTOMS OF GASTROESOPHAGEAL REFLUX [J].
CHERRY, J ;
SIEGEL, CI ;
MARGULIE.SI ;
DONNER, M .
ANNALS OF OTOLOGY RHINOLOGY AND LARYNGOLOGY, 1970, 79 (05) :912-&
[3]  
El-Serag HB, 2001, AM J GASTROENTEROL, V96, P979
[4]   Comorbid occurrence of laryngeal or pulmonary disease with esophagitis in United States military veterans [J].
ElSerag, HB ;
Sonnenberg, A .
GASTROENTEROLOGY, 1997, 113 (03) :755-760
[5]  
Galmiche JP, 1995, EUR J GASTROEN HEPAT, V7, P1152
[6]  
GAYNOR EB, 1988, LARYNGOSCOPE, V98, P972
[7]   Ex juvantibus approach for chronic posterior laryngitis: results of short-term pantoprazole therapy [J].
Habermann, W ;
Eherer, A ;
Lindbichler, F ;
Raith, J ;
Friedrich, G .
JOURNAL OF LARYNGOLOGY AND OTOLOGY, 1999, 113 (08) :734-739
[8]  
HALLEWELL JD, 1970, ARCHIV OTOLARYNGOL, V92, P499
[9]   OUTCOMES OF ANTIREFLUX THERAPY FOR THE TREATMENT OF CHRONIC LARYNGITIS [J].
HANSON, DG ;
KAMEL, PL ;
KAHRILAS, PJ .
ANNALS OF OTOLOGY RHINOLOGY AND LARYNGOLOGY, 1995, 104 (07) :550-555
[10]   Effect of omeprazole on the course of associated esophagitis and laryngitis [J].
Jaspersen, D ;
Hammar, CH ;
Draf, W .
JOURNAL OF GASTROENTEROLOGY, 1996, 31 (06) :765-767